Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
about
Ustekinumab: differential use in psoriasisCharacteristics of patients receiving ustekinumab compared with secukinumab for treatment of moderate-to-severe plaque psoriasis - nationwide results from the DERMBIO registry.Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature.The rapid onset of multiple squamous cell carcinomas in two patients commenced on ustekinumab as treatment of psoriasis.
P2860
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
@en
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
@nl
type
label
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
@en
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
@nl
prefLabel
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
@en
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
@nl
P2860
P1476
Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
@en
P2093
Elizabeth E Uhlenhake
Steven R Feldman
P2860
P304
P356
10.1517/14712598.2010.487061
P407
P577
2010-07-01T00:00:00Z